Immuron (ASX: IMC) Share Price

IMC

$0.034▼-12.82%

$8.8MRank #1543 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$8.8M

Volume

250

P/E Ratio

-1.29

EPS

-$0.007

Dividend Yield

0.00%

52-Week High

$0.098

52-Week Low

$0.026

Beta

0.492

Immuron (ASX: IMC) is an Australian-listed company in the Healthcare sector with a market capitalisation of $8.8M and the 1543rd-largest security on the ASX by market capitalisation. The IMC share price is $0.034, down 12.82% today and down 50.00% over the past 12 months. Shares have traded between $0.026 and $0.098 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Immuron reported revenue of $4.2M and a net loss of $1.9M.

Charts

$0.03

24H Range

$0.034

52-Week Range

$0.026

$0.098

About Immuron Limited

Immuron Limited, an Australian biopharmaceutical firm founded in 1994 and headquartered in Carlton, is dedicated to the exploration, advancement, and worldwide commercialization of polyclonal antibodies. Operating across two divisions—Research and Development, and Hyperimmune Products—the company serves markets in Australia, Israel, Canada, the United States, and other international regions. Its current product portfolio includes Travelan, an over-the-counter remedy aimed at reducing the likelihood of travelers' diarrhea and minor gastrointestinal complaints, which also functions as a dietary supplement for digestive well-being and gut protection. Another offering, Protectyn, is an immune supplement formulated to bolster healthy digestive function and liver support. Beyond its commercialized products, Immuron is actively progressing several pipeline candidates. Travelan (IMM-124E) is currently undergoing a Phase III registration trial in the United States for the prevention of travelers' diarrhea, alongside a Phase II field trial for the same indication, and has demonstrated antiviral efficacy against SARS-CoV-2. Concurrently, IMM-529 is in Phase I/IIa clinical trials, targeting patients with recurrent Clostridium difficile infections. The company has also established key research alliances, including an agreement with the Naval Medical Research Center to develop and clinically evaluate a therapeutic agent against Campylobacter and enterotoxigenic Escherichia coli infections, and a collaborative effort with the Walter Reed Army Institute of Research to create an oral treatment for shigellosis.

IPO Date

30 Apr 1999

CEO

Steven George Lydeamore

Employees

Website

immuron.com.au

Key Financial Data

Revenue (Quarterly)	$4.2M
Net Income (Quarterly)	$-1.9M
Total Assets	$15.1M
Total Debt	$0
Free Cash Flow	$-2.5M
Return on Equity	-14.68%
Profit Margin	-45.86%
Operating Margin	-55.14%

IMC Frequently Asked Questions

What is the Immuron (ASX: IMC) share price?

The IMC share price is $0.034, down 12.82% for the day, based on the latest available ASX market data.

What is Immuron's market capitalisation?

Immuron has a market capitalisation of $8.8M, making it the 1543rd-largest security listed on the ASX.

Does Immuron pay a dividend?

IMC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Immuron profitable?

In its most recent reported period (ending 31 Dec 2025), IMC reported revenue of $4.2M and a net loss of $1.9M.

How many IMC shares are on issue?

Immuron has approximately 257,828,206 shares on issue, based on its market capitalisation of $8.8M and current share price.

What sector is Immuron in?

Immuron is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Immuron list on the ASX?

Immuron listed on the Australian Securities Exchange on 30 Apr 1999.

Latest News

Insights: Immuron Ltd (ASX:IMC)

smallcaps.com.au30 Oct 2025

Insights: Immuron Ltd (ASX:IMC) smallcaps.com.au

Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets

Kalkine Media2 June 2026

Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets Kalkine Media

Immuron (NASDAQ: IMRN) responds to ASX query on share price

Stock Titan28 May 2026

Immuron (NASDAQ: IMRN) responds to ASX query on share price Stock Titan

Immuron (ASX:IMC) Shares Rally on Q3 Sales Boost and Retail Expansion

Kalkine Media17 Apr 2026

Immuron (ASX:IMC) Shares Rally on Q3 Sales Boost and Retail Expansion Kalkine Media

Immuron Limited (ASX:IMC)

intelligentinvestor.com.au28 Sept 2019

Immuron Limited (ASX:IMC) intelligentinvestor.com.au

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
AVEAvecho Biotechnology Limited	$32.6M	$0.011	-2.50	0.00%	▼-15.38%
NOXNoxopharm Limited	$23.7M	$0.077	-3.69	0.00%	▼-3.75%
NC6Nanollose Limited	$18.6M	$0.053	-2.45	0.00%	–+0.00%
BTCBTC Health Limited	$16.1M	$0.052	-58.88	0.00%	–+0.00%
PABPatrys Limited	$14.7M	$0.043	-0.62	0.00%	▲+2.38%
AT1Atomo Diagnostics Limited	$14.4M	$0.016	-4.09	0.00%	▼-5.88%
NTINeurotech International Limited	$13.1M	$0.013	-5.30	0.00%	▲+8.33%
OSLOncoSil Medical Limited	$10.6M	$0.565	-1.00	0.00%	▲+7.62%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.034	$0.034	$0.034	$0.034	250	▼-12.82%
11 June 2026	$0.038	$0.039	$0.037	$0.039	34K	▲+5.41%
10 June 2026	$0.037	$0.037	$0.037	$0.037	51K	▼-11.90%
9 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
8 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
5 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
4 June 2026	$0.042	$0.042	$0.042	$0.042	11K	▼-4.55%
3 June 2026	$0.044	$0.046	$0.044	$0.044	60K	–+0.00%
2 June 2026	$0.044	$0.044	$0.044	$0.044	27K	▼-8.33%
1 June 2026	$0.044	$0.048	$0.044	$0.048	1.9M	▲+20.00%
29 May 2026	$0.04	$0.04	$0.04	$0.04	79K	▼-6.98%
28 May 2026	$0.043	$0.044	$0.039	$0.043	5.4M	▲+34.37%
27 May 2026	$0.031	$0.032	$0.031	$0.032	61K	–+0.00%
26 May 2026	$0.032	$0.032	$0.032	$0.032	4.4K	–+0.00%
25 May 2026	$0.031	$0.032	$0.031	$0.032	142K	–+0.00%
22 May 2026	$0.032	$0.032	$0.032	$0.032	17K	–+0.00%
21 May 2026	$0.033	$0.034	$0.031	$0.032	383K	▲+3.23%
20 May 2026	$0.033	$0.034	$0.031	$0.031	382K	▲+6.90%
19 May 2026	$0.029	$0.029	$0.029	$0.029	7.4K	▼-12.12%
18 May 2026	$0.032	$0.033	$0.032	$0.033	1.4M	–+0.00%
15 May 2026	$0.032	$0.033	$0.032	$0.033	1.2M	▲+17.86%
14 May 2026	$0.026	$0.028	$0.026	$0.028	21K	–+0.00%
13 May 2026	$0.026	$0.028	$0.026	$0.028	21K	–+0.00%
12 May 2026	$0.026	$0.028	$0.026	$0.028	21K	▼-6.67%
11 May 2026	$0.029	$0.03	$0.029	$0.03	606K	▲+3.45%
8 May 2026	$0.027	$0.029	$0.027	$0.029	434K	▲+11.54%
7 May 2026	$0.026	$0.026	$0.026	$0.026	15K	▼-3.70%
6 May 2026	$0.029	$0.029	$0.027	$0.027	465K	▼-3.57%
5 May 2026	$0.028	$0.028	$0.028	$0.028	20K	▼-3.45%
4 May 2026	$0.029	$0.029	$0.029	$0.029	250K	▼-3.33%

About Immuron Limited

IPO Date

30 Apr 1999

CEO

Steven George Lydeamore

Employees

Website

immuron.com.au

IMC Frequently Asked Questions

What is the Immuron (ASX: IMC) share price?

The IMC share price is $0.034, down 12.82% for the day, based on the latest available ASX market data.

What is Immuron's market capitalisation?

Immuron has a market capitalisation of $8.8M, making it the 1543rd-largest security listed on the ASX.

Does Immuron pay a dividend?

IMC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Immuron profitable?

In its most recent reported period (ending 31 Dec 2025), IMC reported revenue of $4.2M and a net loss of $1.9M.

How many IMC shares are on issue?

Immuron has approximately 257,828,206 shares on issue, based on its market capitalisation of $8.8M and current share price.

What sector is Immuron in?

Immuron is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Immuron list on the ASX?

Immuron listed on the Australian Securities Exchange on 30 Apr 1999.

Company

Market Cap

Price

P/E

Div Yield

1D Change

AVEAvecho Biotechnology Limited

$32.6M

$0.011

-2.50

0.00%

▼-15.38%

NOXNoxopharm Limited

$23.7M

$0.077

-3.69

0.00%

▼-3.75%

NC6Nanollose Limited

$18.6M

$0.053

-2.45

0.00%

–+0.00%

BTCBTC Health Limited

$16.1M

$0.052

-58.88

0.00%

–+0.00%

PABPatrys Limited

$14.7M

$0.043

-0.62

0.00%

▲+2.38%

AT1Atomo Diagnostics Limited

$14.4M

$0.016

-4.09

0.00%

▼-5.88%

NTINeurotech International Limited

$13.1M

$0.013

-5.30

0.00%

▲+8.33%

OSLOncoSil Medical Limited

$10.6M

$0.565

-1.00

0.00%

▲+7.62%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.034	$0.034	$0.034	$0.034	250	▼-12.82%
11 June 2026	$0.038	$0.039	$0.037	$0.039	34K	▲+5.41%
10 June 2026	$0.037	$0.037	$0.037	$0.037	51K	▼-11.90%
9 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
8 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
5 June 2026	$0.042	$0.042	$0.042	$0.042	11K	–+0.00%
4 June 2026	$0.042	$0.042	$0.042	$0.042	11K	▼-4.55%
3 June 2026	$0.044	$0.046	$0.044	$0.044	60K	–+0.00%
2 June 2026	$0.044	$0.044	$0.044	$0.044	27K	▼-8.33%
1 June 2026	$0.044	$0.048	$0.044	$0.048	1.9M	▲+20.00%
29 May 2026	$0.04	$0.04	$0.04	$0.04	79K	▼-6.98%
28 May 2026	$0.043	$0.044	$0.039	$0.043	5.4M	▲+34.37%
27 May 2026	$0.031	$0.032	$0.031	$0.032	61K	–+0.00%
26 May 2026	$0.032	$0.032	$0.032	$0.032	4.4K	–+0.00%
25 May 2026	$0.031	$0.032	$0.031	$0.032	142K	–+0.00%
22 May 2026	$0.032	$0.032	$0.032	$0.032	17K	–+0.00%
21 May 2026	$0.033	$0.034	$0.031	$0.032	383K	▲+3.23%
20 May 2026	$0.033	$0.034	$0.031	$0.031	382K	▲+6.90%
19 May 2026	$0.029	$0.029	$0.029	$0.029	7.4K	▼-12.12%
18 May 2026	$0.032	$0.033	$0.032	$0.033	1.4M	–+0.00%
15 May 2026	$0.032	$0.033	$0.032	$0.033	1.2M	▲+17.86%
14 May 2026	$0.026	$0.028	$0.026	$0.028	21K	–+0.00%
13 May 2026	$0.026	$0.028	$0.026	$0.028	21K	–+0.00%
12 May 2026	$0.026	$0.028	$0.026	$0.028	21K	▼-6.67%
11 May 2026	$0.029	$0.03	$0.029	$0.03	606K	▲+3.45%
8 May 2026	$0.027	$0.029	$0.027	$0.029	434K	▲+11.54%
7 May 2026	$0.026	$0.026	$0.026	$0.026	15K	▼-3.70%
6 May 2026	$0.029	$0.029	$0.027	$0.027	465K	▼-3.57%
5 May 2026	$0.028	$0.028	$0.028	$0.028	20K	▼-3.45%
4 May 2026	$0.029	$0.029	$0.029	$0.029	250K	▼-3.33%